A milestone step towards ending HIV': the truth about the PrEP funding decision
A milestone step towards ending HIV': the truth about the PrEP funding decision
- And as we can see from the recent proposal to change the funded brand for HIV treatments tenofovir and entecavir to generic versions, Pharmac has no problem with funding generics and frequently does so once patents expire. Typically we see a list price drop by at least 90% when generics become ...
- And as we can see from the recent proposal to change the funded brand for HIV treatments tenofovir and entecavir to generic versions, Pharmac has no problem with funding generics and frequently does so once patents expire. Typically we see a list price drop by at least 90% when generics become ...